Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-14-074595

Options or other derivatives

  • SVP & Chief Financial Officer acquired 175,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nicholson John · SVP & Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-12-09 Grant or award : show line 1 in the form Stock Option +87,500 $16.31 2022-12-08 87,500 87,500 D
2014-12-09 Grant or award : show line 2 in the form Stock Option +87,500 $16.31 2022-12-08 87,500 87,500 D
Loading xslF345X03/doc4.xml…